Abstract
Fischer F344 rats were given a cyclical diet of 0.06% 2-acetylaminofluorene (AAF), which progressively induced oval cell proliferation, cirrhosis and hyperplastic (or neoplastic) nodules. Primary liver tumours developed from 7 months after ceasing the diet. Liver samples taken during and after AAF administration and specimens of primary tumours were processed into frozen sections and examined microscopically for morphological changes in cell populations, stained histochemically for gamma-glutamyl transpeptidase (GGTase) and four phosphatases, and stained by the immunoperoxidase technique for the presence of antigens detected by seven anti-liver cell monoclonal antibodies and monoclonal antibodies to six oncoproteins. During and after AAF treatment several of the anti-liver antibodies revealed foci of aberrantly or heterogeneously-stained cells, although anti-oncoprotein antibodies showed no consistent changes. Foci of cells positive for GGTase and heterogeneous for adenosine triphosphatase (ATPase) were also seen. Nodules invariably showed heterogeneous antigenicity, raised GGTase and abnormal ATPase expression. Primary tumours exhibited varying degrees of positivity, negativity and heterogeneity with the anti-liver monoclonal antibodies, and all were positive for GGTase. Comparison between various parameters and different lesions showed the greatest concordance between nodules and tumours, suggesting that nodules are probably the precursors of malignant tumours in this system.
Full text
PDF










Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cameron R., Kellen J., Kolin A., Malkin A., Farber E. Gamma-glutamyltransferase in putative premalignant liver cell populations during hepatocarcinogenesis. Cancer Res. 1978 Mar;38(3):823–829. [PubMed] [Google Scholar]
- Corcos D., Defer N., Raymondjean M., Paris B., Corral M., Tichonicky L., Kruh J., Glaise D., Saulnier A., Guguen-Guillouzo C. Correlated increase of the expression of the c-ras genes in chemically induced hepatocarcinomas. Biochem Biophys Res Commun. 1984 Jul 18;122(1):259–264. doi: 10.1016/0006-291x(84)90468-6. [DOI] [PubMed] [Google Scholar]
- Embleton M. J., Butler P. C. Reactivity of monoclonal antibodies to oncoproteins with normal rat liver, carcinogen-induced tumours, and premalignant liver lesions. Br J Cancer. 1988 Jan;57(1):48–53. doi: 10.1038/bjc.1988.7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Embleton M. J., Habib N. A., Garnett M. C., Wood C. Unsuitability of monoclonal antibodies to oncogene proteins for anti-tumour drug-targeting. Int J Cancer. 1986 Dec 15;38(6):821–827. doi: 10.1002/ijc.2910380607. [DOI] [PubMed] [Google Scholar]
- Evan G. I., Lewis G. K., Ramsay G., Bishop J. M. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol. 1985 Dec;5(12):3610–3616. doi: 10.1128/mcb.5.12.3610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FARBER E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-dimethylaminoazobenzene. Cancer Res. 1956 Feb;16(2):142–148. [PubMed] [Google Scholar]
- Farber E. The multistep nature of cancer development. Cancer Res. 1984 Oct;44(10):4217–4223. [PubMed] [Google Scholar]
- Fukumoto T., Kimura H., Naito M., Miyamoto M., Yamashita A., Sugiyama H. Monoclonal antibodies to rat liver cell membrane glycoproteins. Mol Immunol. 1984 Apr;21(4):285–291. doi: 10.1016/0161-5890(84)90099-3. [DOI] [PubMed] [Google Scholar]
- Furth M. E., Aldrich T. H., Cordon-Cardo C. Expression of ras proto-oncogene proteins in normal human tissues. Oncogene. 1987 Mar;1(1):47–58. [PubMed] [Google Scholar]
- Hixson D. C., Allison J. P. Monoclonal antibodies recognizing oval cells induced in the liver of rats by N-2-fluorenylacetamide or ethionine in a choline-deficient diet. Cancer Res. 1985 Aug;45(8):3750–3760. [PubMed] [Google Scholar]
- Manson M. M., Green J. A., Neal G. E. Monoclonal antibody against tumour-derived cell line shows heterogeneity of altered hepatocytes during AFB1-induced carcinogenesis. Int J Cancer. 1984 Dec 15;34(6):869–874. doi: 10.1002/ijc.2910340620. [DOI] [PubMed] [Google Scholar]
- Moore M. A., Nakamura T., Shirai T., Ichihara A., Ito N. Immunohistochemical demonstration of increased glucose-6-phosphate dehydrogenase in preneoplastic and neoplastic lesions induced by propylnitrosamines in F344 rats and Syrian hamsters. Jpn J Cancer Res. 1986 Feb;77(2):131–138. [PubMed] [Google Scholar]
- Pugh T. D., Goldfarb S. Quantitative histochemical and autoradiographic studies of hepatocarcinogenesis in rats fed 2-acetylaminofluorene followed by phenobarbital. Cancer Res. 1978 Dec;38(12):4450–4457. [PubMed] [Google Scholar]
- Scherer E., Emmelot P. Kinetics of induction and growth of enzyme-deficient islands involved in hepatocarcinogenesis. Cancer Res. 1976 Jul;36(7 Pt 2):2544–2554. [PubMed] [Google Scholar]
- Squire R. A., Levitt M. H. Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res. 1975 Nov;35(11 Pt 1):3214–3223. [PubMed] [Google Scholar]
- Williams A. R., Piris J., Spandidos D. A., Wyllie A. H. Immunohistochemical detection of the ras oncogene p21 product in an experimental tumour and in human colorectal neoplasms. Br J Cancer. 1985 Nov;52(5):687–693. doi: 10.1038/bjc.1985.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Williams G. M. Functional markers and growth behavior of preneoplastic hepatocytes. Cancer Res. 1976 Jul;36(7 Pt 2):2540–2543. [PubMed] [Google Scholar]
- Yaswen P., Goyette M., Shank P. R., Fausto N. Expression of c-Ki-ras, c-Ha-ras, and c-myc in specific cell types during hepatocarcinogenesis. Mol Cell Biol. 1985 Apr;5(4):780–786. doi: 10.1128/mcb.5.4.780. [DOI] [PMC free article] [PubMed] [Google Scholar]


